Search

Your search keyword '"A., Pellegatta"' showing total 2,140 results

Search Constraints

Start Over You searched for: Author "A., Pellegatta" Remove constraint Author: "A., Pellegatta"
2,140 results on '"A., Pellegatta"'

Search Results

101. Peroral Endoscopic Myotomy for Achalasia after Bariatric Surgery: A Case Report and Review of the Literature

103. Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group

105. The inflammatory potential of diet is associated with future development of pre-clinical carotid atherosclerosis

110. Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective

111. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real‐world efficacy from the EoE CONNECT registry

112. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study

113. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)

114. Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease

116. Peroral Endoscopic Myotomy Technique, from Mouth to Anus

117. Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps.

119. Two factor-based reprogramming of rodent and human fibroblasts into Schwann cells

121. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

122. End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance

123. Corrigendum to “Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry” [Digestive and Liver Disease Volume 55, Issue 3, March 2023, Pages 350–359]

124. The Complex Work of Proteases and Secretases in Wallerian Degeneration: Beyond Neuregulin-1

125. Corrigendum to 'Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry' [Digestive and Liver Disease Volume 55, Issue 3, March 2023, Pages 350–359]

126. Microbiota Gut–Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease

127. The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group

128. Artificial intelligence in gastroenterology: Where are we heading?

129. Percutaneous endoscopic gastrostomy and jejunostomy: Indications and techniques

133. Alberto Pellegatta (Milán, 1978)

134. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures

135. INNOVATION AND TRADITION: INTEGRATED PRACTICES IN THE ARCHITECTURAL SURVEY OF PRETORIO PALACE IN TRENTO.

136. IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer.

138. Data from Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling

139. Abstract 4694: Single-cell analysis of glioblastoma immune contexture identifies a subset of activated and memory tumor-reactive CD8+ TILs and a Treg signature contributing to TIL irreversible dysfunction

140. Supplementary Figures 1-8 from Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling

141. Gender authorship in major US and European gastroenterology journals: the gap is still unfilled

143. Combination of mucosa-exposure device and computer-aided detection for Adenoma Detection during Colonoscopy: a randomized trial

144. Data from The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

145. Supplementary Table 1 from The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

146. Supplementary Table 7 from The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

147. Supplementary Tables 2-8 from The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

148. Supplementary Table S1 from Neurospheres Enriched in Cancer Stem–Like Cells Are Highly Effective in Eliciting a Dendritic Cell–Mediated Immune Response against Malignant Gliomas

149. Supplementary Materials and Methods and Figures 1 - 3 from Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma

150. Supplementary Materials and Methods from The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

Catalog

Books, media, physical & digital resources